Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Find out which savings strategy is most effective for your financial goals. Implement these strategies for better savings.
26,213 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
SLV has surged about 132% over the past year as inflation fears persist. But the 0.50% annual fee and a 28% tax on co...
Douglas Elliman expands into New Hampshire, recruiting Adam Pettitt to The Sarkis Team and debuting LOOKOUT Lake Winn...
As bond yields wobble, energy stocks secretly better provide income with inflation protection and strong cash flow. E...
A decade-long income lure from QYLD masks a sizable NAV erosion. The ETF's NAV has declined about 35% since its 2013 ...
A note from Standard Chartered suggests bitcoin's bottom could be in sight after a tough week, driven by steady ETF d...
Two international small-cap funds, AVDV and DLS, offer different paths to income in a changing 2026 market. This divi...
Apple warns memory costs may squeeze margins and push pricing for the iPhone 18 cycle. Investors are weighing how you...
A reported FIFA-engineered plan USMNT spurred a country-wide sing-along after matches, signaling potential shifts in ...
A new approach to retirement income uses a dividend growth roadmap that prioritizes rising payouts over static yields...
Warren Buffett publicly stated he initiated Berkshire Hathaway’s larger stake in Alphabet, signaling a top-down push ...
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...